ANIP | ANI PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$72.28
+$1.61 (+2.28%)

ANI Pharmaceuticals (ANIP) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $72.28 vs 50 $72.82 / 200 $77.52
Projection
No cross projected
Test
No active test
Last cross
Death cross 27 Aug 2026 ยท projected 7 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $72.00 vs 50 $78.03 / 200 $64.97
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 12 Jun 2023 ยท projected 24 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $72.28 vs 50 $72.31 / 200 $76.51
Projection
No cross projected
Test
No active test
Last cross
Death cross 12 Aug 2026 ยท projected 8 bars out

Cross history

26
crosses on record since 2017
13 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
27 Aug 2026Death flatdaily7 bars outNot tested
12 Aug 2026Golden flatdaily16 bars outNot tested
12 Aug 2026Death4-hour8 bars outNot tested
5 May 2026Golden4-hour12 bars out2 bar cross test
5 Mar 2026Death moderatedaily25 bars outNot tested

About ANIP

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$24.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.